Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer
Cancer Biomarkers · 12.10.2022 · 35 (2) · 217-225
DOI: 10.3233/cbm-220032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, erschienen am 12.10.2022. Verfasst von Se-Il Go und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeo…. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Endothelial activation and insult may contribute to the aggressive clinical course of small-cell lung cancer (SCLC); however, no predictive biomarker for this pathogenesis has been identified. OBJECTIVE: To evaluate the clinical impact of the endothelial activation and stress index (EASIX) in SCLC. METHODS: In this retrospective study, the EASIX was calculated from measurements of serum lactate dehydrogenase, creatinine, and platelet levels. A total of 264 patients with SCLC treated with platinum-based chemotherapy were stratified into high and low EASIX groups. RESULTS: Complete and objective response rates in the limited-stage (LD) were 19.5% vs. 33.3% (P= 0.050) and 85.4% vs. 97.9% (P= 0.028) in the high and low EASIX groups, respectively. There was no significant difference in the response rate between the two groups in the extensive-stage (ED). The median overall survival was 9.8 vs. 40.5 months in LD (P< 0.001) and 7.2 vs. 11.9 months in ED (P< 0.001) in the high and low EASIX groups, respectively. In multivariate analyses, a high EASIX level was an independent prognostic factor for worse progression-free and overall survival irrespective of stage. CONCLUSION: EASIX may be a potential predictive biomarker of SCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
Zitieren
APA
Go, S. I., Park, S., Kang, M. H., Kim, H. G., Kang, J. H., Kim, J. H., & Lee, G. W. (2022). Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer. Cancer Biomarkers, 35(2), 217-225. https://doi.org/10.3233/cbm-220032
Vancouver
Go SI, Park S, Kang MH, Kim HG, Kang JH, Kim JH, et al. Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer. Cancer Biomarkers. 2022;35(2):217-225. doi:10.3233/cbm-220032
BibTeX
@article{Go2022,
author = {Go, Se-Il and Park, Sungwoo and Kang, Myoung Hee and Kim, Hoon-Gu and Kang, Jung Hun and Kim, Jung Hoon and Lee, Gyeong-Won},
title = {Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer},
journal = {Cancer Biomarkers},
year = {2022},
volume = {35},
number = {2},
pages = {217--225},
doi = {10.3233/cbm-220032}
}
EUVIMED